SEARCH

SEARCH BY CITATION

References

  • 1
    Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605612.
  • 2
    Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365376.
  • 3
    Heeger PS, Hricik D. Immune monitoring in kidney transplant recipients revisited. J Am Soc Nephrol 2002; 13: 288290.
  • 4
    Roberti I, Reisman L. Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry – correlation with clinical outcome. Transplantation 2001; 71: 13171320.
  • 5
    Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P. Subclinical rejection – a potential surrogate marker for chronic rejection – may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000; 5: 4449.
  • 6
    Shulzhenko N, Morgun A, Rampim GF et al. Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum Immunol 2001; 62: 342347.
  • 7
    Ahsan N, Hricik D, Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil – a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 18651874.
  • 8
    Ciubotariu R, Vasilescu R, Ho E et al. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 2001; 62: 1520.
  • 9
    Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947954.
  • 10
    Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252259.
  • 11
    Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 22672275.
  • 12
    Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114119.
  • 13
    Gallucci S, Lolkema M, Matzinger P.Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 12491255.
  • 14
    Ridge JP, Di Rosa F, Matzinger P.A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474478.
  • 15
    Hamann D, Baars PA, Rep MH et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 14071418.
  • 16
    Jha V, Muthukumar T, Kohli HS, Sud K, Gupta KL, Sakhuja V. Impact of cyclosporine withdrawal on living related renal transplants: a single-center experience. Am J Kidney Dis 2001; 37: 119124.
  • 17
    Spitzer TR, Delmonico F, Tolkoff-Rubin N et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480484.
  • 18
    VanBuskirk AM, Heeger PS. Report from ‘The Tolerance Assay. Where are we now?’ Workshop, Transplant 2001. Graft 2001; 4: 571573.
  • 19
    Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI. The role of the allograft in the induction of donor-specific T cell hyporesponsiveness. Transplantation 2001; 72: 480485.
  • 20
    Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients. implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167: 71997206.
  • 21
    Gould DS, Auchincloss H Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20: 7782.
  • 22
    Valdez H, Anthony D, Farukhi F et al. Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. Aids 2000; 14: 22392246.
  • 23
    Heeger PS, Valujskikh A, Lehmann PV. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen. J Immunol 2000; 165: 12781284.
  • 24
    Reinsmoen NL, Matas A, Kaufman D, Sutherland D, Najarian JS, Bach FH. Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. Transplant Proc 1991; 23 (1 Part 1): 141142.
  • 25
    Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 10171023.
  • 26
    VanBuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145155.